Without a template, the biosynthesis of glycans heavily relies on the organisation of enzymes in the Golgi apparatus. In addition, glycan functions often feedback on important basic cell biological processes such as membrane trafficking and signalling. Therefore, understanding the interfaces between intracellular organisation and glycobiology is crucial to provide new tools and understanding for the functional investigation of glycans.
This scientific meeting will bring together glycoscientists with cell biologists to foster new ideas and collaborations between both disciplines. A range of topics from traditional cell and glycobiology through analytics and synthetic carbohydrate chemistry all the way to systems level studies will be explored at the event to encourage more joined-up thinking.
This is a joint between The Biochemical Society and The British Society for Research on Ageing (BSRA).
Estimates suggest that globally there will be over 2.1 billion people aged over 60 by 2050. Increased age is the major risk factor for multiple diseases including cancer, diabetes, cardiovascular disease and neurodegeneration. New strategies to help ensure improved health in older people are therefore urgently needed.
Research has shown that common underlying biological processes, such as nutrient signalling and cellular metabolism, influence the ageing process to drive multiple age-related pathologies; these biological mechanisms of ageing have therefore emerged as viable therapeutic targets for manipulating ageing itself to treat age-related diseases. This conference is jointly organised with the British Society for Research on Ageing (BSRA) and will bring together those working on cellular metabolism with those developing interventions to improve healthy ageing, providing an interdisciplinary forum for discussion on how to translate fundamental scientific findings to clinical strategies that target ageing and its associated diseases.
This meeting is aimed at researchers in a range of disciplines including biochemistry, biology and medicine. The event programme will also include a public session to broaden awareness and provide a balanced view of the most recent scientific evidence relating to health during ageing.
DNA Replication is one of the most fundamental processes in life. Every dividing cell has to duplicate its genome before cell division. Mistakes during DNA replication are a major cause of genomic instability that can lead to cancer development. With this in mind, research into the biochemistry of DNA replication is of high interest for many groups around the world and biotech companies.
The Biochemical Society invites you to submit an abstract for an oral or poster presentation to share your work on a variety of themes, which include:
Origins of replication
Elongation and termination
Replication and chromatin
Replication and transcription
This meeting will provide an excellent opportunity to network with colleagues working in this field. At this event, we will also be welcoming Dr Sara Priego Moreno to present her work as the recipient of the Biochemical Society’s Early Career Researcher 2020 award.
05 October - 06 October
Low molecular weight thiols: lessons learned and new perspectives
Thiol redox reactions are implicated in a diverse range of physiological processes and are often dysregulated in human pathologies such as cancer, neurodegeneration and metabolic disorders. Low-molecular-weight (LMW) thiols play an essential role in maintaining the cellular redox homeostasis and exert important functions in cell growth, metabolism and detoxification pathways.
In the last decade, there have been significant advances in our understanding of redox biology, facilitated by the development of cutting-edge technologies and research tools. This conference will be one of the first to focus on the versatile family of LMW thiols in health and disease, a family which contains structurally and functionally diverse molecules with a range of evolutionary histories.
The programme will give attendees the chance to learn about the most recent developments on the role of LMW thiols in redox regulation, signalling, and health and disease from leading experts in the field, and provide networking opportunities to encourage new collaborative interactions between participants and further advance research in this field.
Synthetic biology is a convergence of multiple fields that can generate both improved understanding of biological systems as well as cutting-edge biotechnology.
Synthetic Biology UK 2020 will explore the unique opportunities of research in a number of areas of synthetic biology, establishing likely future directions and facilitating discussion about appropriate strategies. It will provide an excellent framework for younger scientists and engineers to learn about burgeoning new areas of activity, including the engineering of microbial communities and of microbial-plant interactions.
Mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) are the most common genetic cause of Parkinson’s disease (PD), responsible for up to 2-3% of all PD cases in the UK and up to 40% in some populations. Coupled with its clear genetic links to PD, LRRK2’s status as a complex, multi-domain kinase has led to this protein being flagged as one of the most promising drug targets for Parkinson’s disease.
The field is witnessing major advances in our understanding of the function of LRRK2 and its role in human disease and is the focus for this year’s biennial scientific meeting on LRRK2.
The conference programme will explore the genetic forms of PD, the LRRK2 gene and the LRRK2 protein, as well as the basic LRRK2 signalling mechanisms and physiological and pathological functions of LRRK2. In addition, non-neuronal LRRK2 signalling, particularly with respect to neuroinflammation and the immune system in PD, will be covered, as well as the role of LRRK2 in non-PD conditions.
We are welcoming abstracts for both oral communications and poster presentations, from both industry and academia and across all career stages. The meeting will be of particular interest to those working in biochemistry, neuroscience, biotechnology and pharmaceuticals.
09 May - 13 May
FEBS3+ Meeting: 86th Harden Conference – Machines on Genes
From bacteria to eukaryotes, cells have evolved a remarkable battery of enzymes to deal with the mechanical and topological challenges presented by nucleic acid production, processing and maintenance. A clear view of the biology of the genetic material requires a molecular understanding of how these enzymes function. Such an understanding will enhance our ability to manipulate genome structure and gene expression.
The theme of this meeting revolves around the mechanisms of these enzymes, with particular emphasis on research that integrates structural, biochemical, biophysical and computational approaches. With recent technological advances in imaging (i.e., single-molecule and cryo-electron microscopies), we expect to witness a flourish of key biological systems to be characterised with unprecedented detail.
The meeting will cover many of the molecular mechanisms by which large macromolecular machines carry out a diverse range of nucleic acid processes including DNA replication and repair, gene transcription and regulation, RNA processing and splicing, translation, nucleic acids structures and chromatin structure and epigenetic mechanisms. The meeting will also explore new quantitative techniques as well as theoretical approaches.